相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacology of the New Treatments for Lower Gastrointestinal Motility Disorders and Irritable Bowel Syndrome
M. Camilleri
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Performance characteristics of the measurement of gastric volume using single photon emission computed tomography
M. Breen et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2011)
Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functions
A. Deiteren et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2010)
Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort
N. Manabe et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2010)
Peripheral motor action of glucagon-like peptide-1 through enteric neuronal receptors
A. Amato et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2010)
Clinical trial: the glucagon-like peptide-1 analogue ROSE-010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo-controlled, double-blind study
P. M. Hellstrom et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Heightened colon motor activity measured by a wireless capsule in patients with constipation: relation to colon transit and IBS
William L. Hasler et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
GLP-1: Broadening the incretin concept to involve gut motility
Per M. Hellstrom
REGULATORY PEPTIDES (2009)
Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans
Adil E. Bharucha et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)
The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double-blind, placebo-controlled crossover study
Adrian Vella et al.
CLINICAL ENDOCRINOLOGY (2008)
Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome
Michael Camilleri et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome
P. M. Hellstrom et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2008)
Glucagon-like peptide 1 based therapy for type 2 diabetes
Bao-Sheng Yu et al.
WORLD JOURNAL OF PEDIATRICS (2008)
Nitrergic contribution to gastric relaxation induced by glucagon-like peptide-1 (GLP-1) in healthy adults
Christopher N. Andrews et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Glucagon like peptide-1 accelerates colonic transit via central CRF and peripheral vagal pathways in conscious rats
Yukiomi Nakade et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2007)
Central glucagon like peptide-1 delays solid gastric emptying via central CRF and peripheral sympathetic pathway in rats
Yukiomi Nakade et al.
BRAIN RESEARCH (2006)
Integrated upper gastrointestinal response to food intake
Michael Camilleri
GASTROENTEROLOGY (2006)
Functional bowel disorders
George F. Longstreth et al.
GASTROENTEROLOGY (2006)
The physiology of gastric emptying
Per M. Hellstrom et al.
BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY (2006)
The association of gastrointestinal symptoms with weight, diet, and exercise in weight-loss program participants
RL Levy et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Contraction induced by glicentin on smooth muscle cells from the human colon is abolished by exendin (9-39)
SE Ayachi et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2005)
Comparison of gastric volumes in response to isocaloric liquid and mixed meals in humans
H De Schepper et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2004)
Obesity is associated with increased risk of gastrointestinal symptoms: A population-based study
S Delgado-Aros et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Glucagon-like peptide-1 synthetic analogs: New therapeutic agents for use in the treatment of diabetes mellitus
GG Holz et al.
CURRENT MEDICINAL CHEMISTRY (2003)
SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication
EP Bouras et al.
GUT (2002)
Performance characteristics of scintigraphic transit measurements for studies of experimental therapies
F Cremonini et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome
CM Prather et al.
GASTROENTEROLOGY (2000)
分享论文
